Background. Systemic sclerosis (Ssc) is an autoimmune disease characterized by cutaneous and visceral fibrosis and its pathogenesis is incompletely understood. T helper cells are key regulators of the immune response and they seem to be involved in Ssc clinical manifestations. The aim of the study is to determine key cytokines secreted by Th1 (IFN-γ), Th2 (IL-6) and Th17 (IL-17) in Ssc patients and correlate them with specific manifestations of Ssc patients.
Material and methods. 35 consecutive Ssc patients and 20 age and sex matched controls were recruited. Serum IL-17, IFN-γ and IL-6 were determined using ELISA method.
Results. Serum IL-17 and IL-6 levels were not significantly different in Ssc patients and controls. Serum IFN-γ levels were higher in Ssc patients when compared to controls. Higher serum IFN-γ levels associated with pulmonary hypertension. After adjusting for gender and age, IL-17 levels remained independently associated with some clinical manifestations of Ssc patients (telangiectasia and high activity score of Ssc).
Conclusion. Th17 and Th1 cell responses are active in Ssc patients as their cytokines associated with higher disease activity scores and pulmonary manifestations. Th17 and Th1 specific activity and homing within Ssc patients still needs to be defined and determined in order to target them as potential future therapeutic targets in Ssc patients.
Keywords
- IL-17
- systemic sclerosis
- IFN-γ
- T helper 17
- T helper 1
A Practical Review of Diabetes Mellitus Type 2 Treatment in Primary Care Lupus-related protein-losing enteropathy associated with pseudo–pseudo Meigs’ syndrome and successfully treated with hydroxychloroquine COVID-19: a trigger for severe thrombotic microangiopathy in a patient with complement gene variant The Frailty Phenotype in Hemodialysis Patients and its Association with Biochemical Markers of Mineral Bone Disorder, Inflammation and Nutrition Hyper-inflammation after COVID-19 mARN vaccination: at the crossroads of multisystem inflammatory disease and adult-onset Still’s disease. Does terminology matter? Non secretory myeloma in young man mimicking the Gorham disease: case report and the literature review Association between admission blood glucose and prognosis in non-diabetic patients with first-ever acute myocardial infarction Discontinuation of Eculizumab treatment after hematological remission in patients with atypical and drug-induced hemolytic uremic syndrome Anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis caused by bacterial organizing pneumonia in a patient with Sjogren syndrome Acute myelogenous leukemia – current recommendations and approaches in molecular-genetic assessment Peculiar encounter of sarcoidosis and solid pseudopapillary tumor of the pancreas Systematic Approach to Celiac Disease: A Comprehensive Review for Primary Providers The role of thyroid hormones in carotid arterial wall remodeling in women Serum Uric Acid as a Predictor of cardio-and cerebro-vascular diseases in Maintenance Hemodialysis Patients Anti - Dense Fıne Speckled (DFS) Antibody: its staınıng pattern in indirect immunofluorescence and its clinical relevance Cardiac biomarkers alterations in patients with SARS-CoV-2 infection Characteristics and outcomes of patients with COVID-19 and liver injury: a retrospective analysis and a multicenter experience Autoimmune Polyglandular Syndrome Type II presenting as Subacute Combined Degeneration of Spinal Cord: A Neuroendocrinology Crossroad Erratum for the paper Erfani A. Liver Fibrosis: Causes and Methods of Assessment, A Review. Rom J Intern Med. 2015;53(4):304-14.
